Sculptor Capital LP Sorrento Therapeutics, Inc. Put Options Transaction History

Sculptor Capital LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$2.0 - $4.9 $17,200 - $42,140	-8,600 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.41 - $10.99 $935,883 - $1.39 Million	-126,300 Reduced 93.62%	8,600 $66,000
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $19,008 - $39,435	-3,300 Reduced 2.39%	134,900 $921,000
Q3 2020 Nov 12, 2020	BUY	$6.17 - $18.82 $200,525 - $611,650	32,500 Added 30.75%	138,200 $1.54 Million
Q2 2020 Aug 14, 2020	SELL	$1.73 - $6.76 $81,310 - $317,720	-47,000 Reduced 30.78%	105,700 $663,000
Q2 2018 Aug 13, 2018	BUY	$4.75 - $8.0 $725,325 - $1.22 Million	152,700 New	152,700 $1.1 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.